Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients January 13, 2020
Lysergic acid diethylamide as an analgesic agent in patients with terminal illnesses December 19, 2019
4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels December 11, 2019
Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment December 10, 2019
The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression September 11, 2019
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders August 27, 2019
Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action March 22, 2019
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety March 1, 2019
Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder February 21, 2019
